Sanofi (SNY) Net Margin (QoQ) (2009 - 2026)
Sanofi (SNY) Net Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.18 Bn | 632.42 Bn | 17.26 Bn |
| 2 | AbbVie | 470.13 Bn | 463.56 Bn | 12.70 Bn |
| 3 | Merck | 376.16 Bn | 369.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.69 Bn | 295.00 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.73 Bn | 252.83 Bn | 12.86 Bn |
| 6 | Amgen | 236.53 Bn | 222.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.21 Bn | 180.03 Bn | 6.22 Bn |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn |
| 9 | Gsk | 105.91 Bn | 101.75 Bn | 8.24 Bn |
| 10 | Sanofi | 55.25 Bn | 47.87 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,173.00 |
| Mar 31, 2026 | -6,166.00 |
| Dec 31, 2025 | 5,037.00 |
| Sep 30, 2025 | -1,277.00 |
| Jun 30, 2025 | 2,051.00 |
| Mar 31, 2025 | 1,116.00 |
| Dec 31, 2024 | -1,540.00 |
| Sep 30, 2024 | 1,135.00 |
| Jun 30, 2024 | -88.00 |
| Mar 31, 2024 | 1,415.00 |
| Dec 31, 2023 | -2,257.00 |
| Sep 30, 2023 | 670.00 |
| Jun 30, 2023 | -512.00 |
| Mar 31, 2023 | 322.00 |
| Dec 31, 2022 | -33.00 |
| Sep 30, 2022 | 502.00 |
| Jun 30, 2022 | -915.00 |
| Mar 31, 2022 | 249.00 |
| Dec 31, 2021 | -387.00 |
| Sep 30, 2021 | 844.00 |